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A kinetic peptide fragmentation model for quantitative prediction of peptide CID spectra in an
ion trap mass spectrometer has been reported recently. When applying the model to predict
the CID spectra of large peptides, it was often found that the predicted spectra differed
significantly from their experimental spectra, presumably due to noncovalent interactions in
these large polypeptides, which are not considered in the fragmentation model. As a result,
site-specific quantitative information correlated to the secondary/tertiary structure of an
ionized peptide may be extracted from its CID spectrum. To extract this information, the
kinetic peptide fragmentation model was modified by incorporating conformation-related
parameters. These parameters are optimized for best fit between the predicted and the
experimental spectrum. A conformational stability map is then generated from these confor-
mation-related parameters. Analysis of a few bioactive -helical peptides including melittin,
glucagon and neuropeptide Y by this technique demonstrated that their stability maps in the
gas phase correlate strongly to their secondary structures in the condensed phases. (J Am Soc
Mass Spectrom 2006, 17, 786–794) © 2006 American Society for Mass SpectrometryHow a one-dimensional polypeptide chain foldsinto a three-dimensional biologically activeform is one of the greatest challenges in life
science. One approach to understand the role of solvent
in this folding process is to study protein conformation
in the gas phase, in the absence of solvent. Understand-
ing the relationship between the gas-phase and con-
densed-phase protein conformations will also help us
evaluate mass spectrometry as a tool for studying
protein noncovalent interactions.
Protein conformation and dynamics in the con-
densed phases has traditionally been studied by X-ray
crystallography [1], nuclear magnetic resonance spec-
troscopy [2–4], circular dichroism [5], etc., as well as
hydrogen exchange [6, 7] and its recent combination
with mass spectrometry [8–11]. Compared to the large
amount of knowledge about protein conformation in
the condensed phases, little is known about the confor-
mation of proteins in gas phase, largely due to the lack
of structurally informative techniques to study gas-
phase proteins [12, 13]. Techniques including collision
cross-section measurement [14–21] and hydrogen/deu-
terium exchange [22–27] have been used to study pro-
tein gas-phase conformation, but they provide limited
structural details. Recently, electron-capture dissocia-
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tron resonance mass spectrometry shed some light on
the structural details of gaseous proteins [28–30]. This
paper reports a new methodology, based on collision-
induced dissociation (CID) spectra of peptides or pro-
teins, for structural details of gaseous peptides or pro-
teins that compliments the information obtained from
ECD and other conventional techniques. Smith and
coworkers first demonstrated that CID spectra could be
used as a probe for protein conformation [31]. Cassady
and Carr also used CID to probe conformation of
ubiquitin ions [24]. However, the information derived
from these experiments was largely qualitative. To
derive conformation-related information from protein/
peptide CID spectra that is more quantitative in nature,
the effects of primary sequence to the CID spectra need
to be quantitatively removed.
A kinetic peptide fragmentation model for simulat-
ing peptide CID spectra in an ion trap mass spectrom-
eter has been reported recently [32, 33]. The model
contains parameters describing the kinetics of the frag-
mentation processes during a CID experiment, such as
activation energy (Ea) and gas-phase basicity (GB)
associated with each amino acid residue. In the model,
the distribution of charges is first calculated according
to GB of each protonation site. The rate constant for
each fragmentation pathway is then calculated, using
Arrhenius equation, based on Ea and pre-exponential
frequency factor for the specific pathway and cleavage
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based on the charge distribution and fragmentation rate
constants for all competing pathways.
The kinetic model has been shown quite accurate in
predicting peptide CID spectra, especially for relatively
small peptides, and has been successfully used for
reliable de novo sequencing [34]. For large peptides or
proteins, however, the predicted spectra often differed
significantly from their experimental spectra, presum-
ably due to noncovalent interactions in these large
polypeptides, which are not considered in the fragmen-
tation model. If this is indeed the underlying cause for
the observed discrepancies between predicted and ex-
perimental CID spectra, then site-specific quantitative
information correlated to the secondary/tertiary struc-
ture of an ionized peptide may be extracted from its
CID spectrum. We found that it is indeed possible to
generate a stability map for a gas-phase peptide ion
using this approach. Analysis of a few bioactive -he-
lical peptides by this technique demonstrated that the
stability maps of these polypeptides in the gas phase
correlate strongly to their secondary structures in the
condensed phases.
Computational Method
The noncovalent structure of a peptide is assumed to
affect its fragmentation spectrum by the following
mechanisms (1). Peptide backbone cleavages involve a
rearrangement of the peptide conformation near the
cleavage site [35–37]. To facilitate this conformational
rearrangement, the conformation near the cleavage site
must be flexible. Therefore, when noncovalent interac-
tions are present near a backbone cleavage site, an extra
amount of energy is required to break these noncova-
lent interactions before the peptide bond can be
cleaved. This extra energy, called conformational stabi-
lization energy and designated as EB, is added to the
Ea for each backbone cleavage (2). GB of basic side
chains can be altered by salt bridges and other environ-
mental factors. This change in GB of each basic residue
is designated as GB (3). Ea for side-chain neutral losses
can also be affected by local conformation of the pep-
tide. This change in Ea for each side-chain neutral loss
is designated as ES. To account for the discrepancies
between predicted and experimental CID spectra, the
above conformation-related parameters were included
in the quantitative peptide fragmentation model for
simulating the peptide CID spectrum. The values of
these parameters were determined by maximizing the
similarity between the predicted and experimental
spectra as defined in the following equation [32]
s
Im1 Im2
 Im1  Im2 
(1)where Im
1 and Im
2 are intensities of an ion at m/z  m forthe two spectra. Two ions are considered the same ion
if their m/z ratios differ by less than 0.4 u.
All experimental spectra contain noise. An absolute
best fit of the model to the experimental spectrum will
generate a solution that contains large amount of noise,
which may be interpreted as useful information. In this
case, the model is over-fitted. To avoid over-fitting the
model to the experimental spectrum, the dispersion of
the values for the parameters EB, GB, and ES is
minimized at the same time when similarity between
the predicted and the experimental spectra is maxi-
mized. In practice, the Q values described in the follow-
ing equation is maximized when determining the val-
ues of EB, GB, and ES.
Q sd (2)
where s is the similarity between the predicted spec-
trum and experimental spectrum defined in eq 1, and d
is the dispersion of these conformation-related param-
eters as defined in eq 3. The weight factor  is set as the
largest value that does not change s significantly when
Q is maximized. In this work,  is set at 0.002, when the
optimized value of s typically decreases by less than
0.01 when compared to a  value of zero.
dEBi EBi1EBi1 ⁄ 22N 1

1
4EB2N 1 GB2NBasic ES
2
NS
(3)
In eq 3, N represents the total number of residues in the
peptide. NBasic represents the total number of basic
sites in the peptide, including the N-terminal amine and
side chains of any arginine, histidine or lysine residues.
NS stands for the total number of sites that may gener-
ate neutral losses, including the N- and C-termini as
well as the side chains of aspartic acid, glutamic acid,
serine, threonine, lysine, arginine, asparagine, and glu-
tamine residues. The first term in eq 3 defines the
deviation of EB of one site from its two neighbors.
Minimizing d ensures that the conformational stability
map (the profile of EB versus residue number) is
smooth and the magnitude of all conformation related
parameters are reasonably small.
When optimizing Q using Powell’s direction set
function optimization method [38], it was found that
different starting points generate different solutions
with similar optimized Q values, indicating that more
than one solution fit the experimental spectrum equally
well. To resolve this problem, a simulated annealing
method [39] was used to find 20 reasonably good
solutions, followed by Powell’s method to find the local
maximum of Q around each of the 20 solutions. The
average EB values and their standard deviations were
plotted against the residue number as the gas-phase
conformational stability map.
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Honey bee venom melittin, porcine pancreas glucagon,
and human neuropeptide Y (Sigma, Saint Louis, MO)
were separately dissolved in water to a concentration of
200 pmol/L, and analyzed on a Thermo Finnigan LTQ
(San Jose, CA) linear ion trap mass spectrometer
equipped with a static nanoelectrospray ionization
source (Thermo) at a needle voltage of 1.0 kV and
heated capillary temperature of 200 °C.
Tandem mass spectra of ions of interest were ac-
quired with an activation time of 30ms, activation q of
0.25, isolation window of 3.0–4.0 u and normalized
collision energy of 14–26%. The collision energies were
optimized to make the parent ions barely observable.
Each spectrum was accumulated for three minutes in
centroid mode.
To obtain large number of backbone cleavages,
which are necessary for deducing maximal and reliable
conformation-related parameters, the number of
charges on a protonated peptide is preferably larger
than the number of arginine residues in the peptide.
When the number of charges is less or equal to the
number of arginine residues in the peptide, these
charges will all be sequestered on the basic arginine
side chains and unable to move to the backbone to
induce fragmentation [36, 40]. For maximal informa-
tion, only those parent ions with charge states larger
than the number of arginine residues in the peptide are
included for the analysis.
Results and Discussion
Gas-Phase Conformational Stability Map
Triply charged melittin is used here as an example to
illustrate how a gas-phase conformational stability map
is derived. Figure 1 (top) shows the tandem spectrum of
triply charged melittin. For triply charged melittin
(GIGAVLKVLTTGLPALISWIKRKRQQ-NH2), two pro-
tons are sequestered by the two arginine side chains,
leaving one proton freely movable across the backbone
to cause fragmentation. Therefore, one expects to see
strong b13 and/or y13 ions due to the labile L13-P14
cleavage. Indeed, strong b13 and y13 ions were pre-
dicted in the simulated tandem spectrum of melittin
(3) as shown in Figure 1 (middle) [33]. However, little
of these ions were observed in the experimental spec-
trum. Similarly, b16 and b17 ions were predicted to be
present in the spectrum, but not seen in the experimen-
tal spectrum at all. On the other hand, the y15 ion
(T11-G12 cleavage), which was predicted weak in the
simulated spectrum, turned out to be strong in the
experimental spectrum.
The discrepancies between the simulated spectrum
and experimental spectrum are attributed to the confor-
mation of the peptide, which is not modeled when
predicting the tandem spectrum. The kinetic model
describing the fragmentation process was modified byadding conformation related parameters EB, GB, and
ES (see Computational Method section). These confor-
mation-related parameters in the model were deter-
mined by maximizing Q as shown in eq 2. Simulated
annealing followed by function optimization was used
to derive 20 solutions with optimized Q values. After
applying these optimized values of EB, GB, and ES
to the fragmentation model, the similarity score of the
predicted spectrum increased from 0.747 to an average
of 0.880. Figure 1 (bottom) shows one of the predicted
spectra after taking conformation effects into account. It
can be seen that the predicted spectrum is now closely
similar to the experimental spectrum.
Among the conformation-related parameters, EB
values are of particular importance because every back-
bone peptide bond has a corresponding EB value,
while only basic residues have GB values and only
residues with neutral losses have ES values. GB
values do provide some information, but the informa-
tion is very limited due to limited number of basic
residues in a peptide. It was found that the trend of ES
values generally agrees with that of EB values. How-
Figure 1. Comparison of experimental tandem spectrum of
melittin (3) with its predicted spectra before and after consider-
ing the conformation effects. The predicted spectrum without
considering the conformational effects (middle) is quite different
from the experimental spectrum (top). After conformational ef-
fects are taken into account by optimizing the EB, GB, and ES
values, the predicted spectrum (bottom) is closely similar to the
experimental spectrum.ever, the ES curves are generally noisier than the EB
789J Am Soc Mass Spectrom 2006, 17, 786–794 PEPTIDE GAS-PHASE CONFORMATION BY CIDcurves, presumably because neutral-loss ions are usu-
ally weak and they are second-generation ions, which
are more difficult to simulate. Because the GB and ES
values contain more noise and less information, they
are not presented.
From the 20 sets of determined EB, GB and ES
values, the EB values were plotted against the residue
number to get a gas-phase conformational stability
map. In a conformational stability map as shown in
Figure 2, the solid curve represents the average EB
values and the shaded area designates one standard
deviation around the average EB value for each pep-
tide bond. In Figure 2 and later, the peptide bond
between residues n and n  1 is represented as the
residue n in the horizontal axis. In a conformational
stability map, a higher value of conformational stabili-
zation energy EB indicates a more stable (or less
flexible) local conformation and a lower value of EB
indicates a less stable (or more flexible) local conforma-
tion. Large standard deviation (larger shaded area)
indicates that the EB values cannot be determined
decisively.
Since the fragmentation process is a competition of
many pathways, changing the activation energies of all
competing pathways by the same amount will change
rate constants of all competing pathways by the same
factor, and thus will not change the resulting predicted
spectrum significantly. Therefore, when the EB values
are calculated several times by simulated annealing/
function optimization without restricting the absolute
values of the conformation related parameters (terms
2–4 in eq 3), conformational stability maps with similar
shapes but different energy offsets will be obtained.
Terms 2–4 in eq 3 are therefore applied to keep all
conformation related parameters close to zero. As a
result of minimizing the dispersion shown in eq 3, the
EB values in all conformational stability maps will be
close to zero and their absolute values will have no
physical meanings. Therefore, the maps show no over-
all stability of the peptide ions.
The stability map shown in Figure 2 indicates a
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Figure 2. Gas-phase conformational stability map of melittin
(3).flexible region around residues T11 and a stable regionaround residue L13-Q26, which explains the strong y15
ions and the absence of b13, b16, and b17 ions in the
experimental spectrum.
Gas-Phase Conformation of Melittin
Melittin is a 26-residue peptide found in bee venom. In
crystal [41, 42] and some nonpolar environments [43] as
well in multimeric form [44], melittin is an -helical
peptide consisting of two -helices with a bend between
residues Thr-11 and Gly-12. Molecular dynamics simu-
lation [45, 46] also predicted two stable -helical regions
and a flexible region around residues Thr-11 and Gly-
12. The high flexibility around residue Thr-11 is due in
part to the presence of a proline at position 14, which
results in a “missing” hydrogen bond in the largely
-helical structure. The C-terminal helix is found more
stable than the N-terminal helix by molecular dynamics
simulation [46].
Figure 3 shows the gas-phase conformational stabil-
ity maps of different charge states of melittin compared
to its crystal structure [41]. Also included in the com-
parison are the crystallographic temperature factors of
melittin. Temperature factors reflect the flexibility of
atoms in the crystalline state [1]. Thus, the temperature
factor versus residue number plot can be viewed as the
conformational stability map in the crystalline state. A
high-temperature factor indicates a more flexible region
in the molecule. In Figure 3, the average temperature
factor of the four backbone atoms (N, C-, C, and O)
was used for each residue.
The temperature factors of melittin show a flexible
region near residues Thr-11 and Gly-12. Comparison of
the gas-phase conformational stability map to the sta-
bility map demonstrated in the temperature factors
indicates correlations between the condensed-phase
conformation and gas-phase conformation of 3 and
4 melittin ions. First, both 3 and 4 melittin ions
show a flexible region near residues Thr-11 and Gly-12,
which corresponds exactly to the flexible region deter-
mined by crystallography and other methods. Compar-
ing to the flexible region near Thr-11 and Gly-12, the
N-terminal and C-terminal regions, which correspond
to two -helices in the condensed phases, are more
stable in the gas phase. While general correlation exists
between the gas phase and condensed phases in terms
of the flexible region and two -helical regions, the two
-helical regions do not have equivalent stabilities in
the gas phase. For 4 and especially 3 melittin ions,
the C-terminal helix is found to be more stable than the
N-terminal helix in the gas phase. This is also true for
mellitin in solution, as determined by molecular dy-
namics simulation [46]. In condensed phases, the two
terminals of a peptide are usually more flexible (the
“end effects”), as seen in the temperature factors in
Figure 3. In gas phase, however, the stability on both
terminals of the 3 and 4 melittin ions does not seem
to decrease very much. Considering that -helices are
primarily held together by hydrogen bonds, and the
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gas phase [47, 48], which is five-time stronger than in
solution [48–50], it is reasonable to believe that the
terminals of an -helix are more stable in the gas phase
than in condensed phases. Other than the “end effects”,
the correlations between the stability maps in the con-
densed phases and gas phase for 3 and 4 melittin
ions indicate that gaseous melittin ions up to four
Figure 3. Conformational stability (EB) maps of different
charge states of melittin compared to its crystal structure and
temperature factors (B).charges have a similar secondary structure as melittin inthe condensed phases. This conclusion is consistent
with the previous result that triply charged melittin
retains its condensed phase secondary structure in the
gas phase, as studied by intercharge repulsion measure-
ment and molecular mechanics calculation [51]. For the
5 melittin ion, as seen in Figure 3, a major conforma-
tional change occurs as indicated by the flexible N-
terminal and C-terminal regions.
Note that it is not possible to assign secondary
structures based on the gas-phase stability map alone.
For example, the N-terminal region of the triply
charged melittin may look too flexible to be an -helix.
The authors merely like to point out the correlation
between the stability maps in the gas phase and the
condensed phase. In addition, because the absolute
values of EB have no physical meanings, the overall
up-shift of the map for the 5melittin ions by no means
suggests that the 5 ions are more stable than the 3
and 4 ions.
Gas-Phase Conformation of Glucagon
Glucagon is a polypeptide hormone consisting of 29 amino
acid residues. The structure of porcine pancreas glucagon
(HSQGTFTSDYSKYLDSRRAQDFVQWLMNT), as deter-
mined by X-ray crystallography [52], contains an -helix
from residues Phe-6 to Leu-26 with the two terminus rather
flexible. Figure 4 shows the gas-phase conformational stabil-
ity maps of different charges of glucagon ions compared to
its crystal structure. Temperature factors were not shown
because they were not determined accurately due to the
limited resolution (3 Å) of the determined crystal structure.
The-helical region of the peptide is generally more stable in
the gas phase than the flexible terminal regions for 3 and
4 ions. For the 5 glucagon ion, the peptide becomes
flexible near Asp-15 and Ser-16, suggesting a disruption of
the helical structure at higher charge states.
Gas-Phase Conformation of Neuropeptide Y
Neuropeptide Y is a polypeptide with 36 residues and is the
most abundant neuropeptide in mammalian central nervous
system. The structure of human neuropeptide Y (YPSKPD-
NPGEDAPAEDMARYYSALRHYINLITRQRY-NH2) as de-
termined by NMR in solution [53] contains a stable -helix at
the C-terminal 24 residues (P13-Y36) and flexible N-terminal
12 residues.
Because neuropeptide Y contains four arginine resi-
dues, the CID spectra of 3 and 4 ions of the peptide
were not included in the analysis. Figure 5 shows the
conformational stability maps of neuropeptide Y (5)
compared to its solution structure determined by NMR.
The -helical region of the peptide is clearly more stable
than the flexible N-terminal region in the gas phase. In
fact, no significant cleavages were observed between
residues A18 and R35 in the CID spectra (not shown) of
neuropeptide Y (5), which by itself indicates second-
ary structure in this region. The large standard devia-
tions in the C-terminal -helical region indicate that the
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sively, due to the lack of fragment ions from cleavages
in this region. However, the fact that even the lower
part of the shaded area in the C-terminal region is
significantly higher than the N-terminal region indi-
cates that the C-terminal region is more stable than the
N-terminal region. The observation that the C-terminal
-helical region is more stable than the N-terminal
region indicates that the C-terminal -helix of neu-
ropeptide Y likely remains intact in the gas phase, and
Figure 4. Conformational stability maps of different charge
states of glucagon compared to its crystal structure.the N-terminal region remains flexible. It is noted thatthe three proline residues at sites 2, 5, and 8 are likely
the reason for an unstable structure in the N-terminal
region.
Vacuum as a Nonpolar Environment
In aqueous solution, the -helices in all three peptides
are not stable when the peptides are in their monomeric
forms [54–56]. These -helices, however, are stabilized
by hydrophobic environments such as in methanol [43],
chloroethanol [57], and trifluoroethanol [56, 58]. Part of
the reason for stabilized -helices is that these nonpolar
solvents stabilized the hydrogen bonds in the -helices.
In gas phase, however, the -helices seem to be quite
stable except at high charge states, as seen from the
gas-phase stability maps. In the absence of solvent,
intramolecular hydrogen bonds are much stronger be-
cause of the lack of competition from polar solvent
molecules. In that respect, vacuum can be viewed as an
ultimate nonpolar environment [51].
Peptide Fragmentation as a Probe for Gas-Phase
Conformation
Melittin monomer contains as many as 20 hydrogen
bonds according to its crystal structure [41, 42]. Consid-
ering that each hydrogen bond has a bond strength of
about 5–6 kcal/mol in the gas phase [47, 48], breaking
all these 20 hydrogen bonds requires more than 100
kcal/mol of energy, which is far more than the energy
require to break a backbone amide bond, which is about
40 kcal/mol [59, 60]. Therefore, it is logical to believe
that only a few hydrogen bonds near the cleavage site
Figure 5. Conformational stability map of neuropeptide Y (5)
compared to its solution structure determined by NMR.
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fragmentation, while the hydrogen bonds in the rest of
the molecule remains similar to the ground state. The
strong correlations of the gas-phase stability maps to
the condensed-phase secondary structures of the three
peptides demonstrated that this is indeed the case. The
conformational stabilization energy described in the
model reflects the amount of energy necessary to break
those hydrogen bonds near the cleavage site.
Based on the above argument, it can be proposed
that different fragmentation channels go through differ-
ent transition states. Take the triply charged melittin for
example; to form the y15 ions (cleavage between T11
and G12), only the hydrogen bonds near the flexible
T11-G12 region need to be disrupted in the transition-
state, while the two -helices largely remain intact. A
strong y15 ion is observed because little extra energy is
required to break the hydrogen bonds near the flexible
T11-G12 region. However, in the transition states to
form b16 or b17 ions (L16-I17 and I17-S18 cleavages),
the C-terminal -helix has to be disrupted, which takes
much more energy. This explains why b16 and b17 ions
are not observed in the experimental spectrum. The
above argument, however, implies that the described
technique may not be suitable to study conformation of
small peptides. In a small peptide, the energy required
to completely disrupt the noncovalent structure is
small. Therefore, the conformation of its transition
states may have no resemblance to its ground state.
For a large polypeptide such as a globular protein
with extensive tertiary structure, care must be taken
when interpreting the results. The presented model
assumes that the rate-limiting step in a protein frag-
mentation is the cleavage of the covalent peptide bond.
This may be true for a smaller peptide without much
tertiary structure. For a protein with extensive tertiary
structure, however, this may not be true because the
separation of the two fragments after a bond cleavage
may become the rate-limiting step due to strong long-
range tertiary interactions. In that case, the conforma-
tional stabilization energy modeled here may not reflect
the conformation stability near the cleavage site. Fur-
ther investigations need to be conducted to determine
which of the two processes is the rate-limiting step for
globular proteins before the data obtained from the
described technique can be appropriately interpreted.
Of course, to generate any useful data for larger pro-
teins, a high-resolution instrument such as a Fourier-
transform ion-cyclotron resonance mass spectrometer is
needed [31], with an appropriate fragmentation model
developed.
A protein ion of the same charge state may have
more than one conformation in the gas phase, as
detected by gas-phase hydrogen/deuterium exchange
[22, 24, 26, 61] and ion mobility study [62]. While
Cassady and Carr found that for the 12 ubiquitin ions,
the two conformations are clearly distinguishable in a
CID experiment [24], Clemmer and coworkers reported
that for ubiquitin ions with 8–10 charges, the CIDspectra of a single charge state appear to be identical for
different conformations, indicating that different con-
formers of each charge state rearrange to similar disso-
ciation transition states before fragment formation [63].
This phenomenon suggests that “weak” noncovalent
interactions contribute to the difference in the tertiary
structure of ubiquitin, as opposed to the “strong”
noncovalent interactions such as those hydrogen bonds
in an -helix. These weak interactions cause protein
ions of the same charge state to fold differently and
exhibit different collisional cross-sections. These weak
interactions are removed during the CID process, leav-
ing only strong interactions in the transition-state. This
hypothesis explains why ions of different collisional
cross-sections have the same fragmentation spectra. The
fact that the two different conformations in 12 ubiq-
uitin ions are distinguishable by CID suggests that the
difference between the two conformations involves
some strong interactions. Collisional cross-section mea-
surement, H/D exchange and recently used electron
capture dissociation may reflect more of the most stable
conformation of the protein because the protein ions are
not heated, they do not distinguish strong interactions
from weak interactions. CID reflects only the effects of
strong interactions such as hydrogen bonds. The effects
of weak interactions responsible for tertiary structures
are often negligible in comparison. Therefore, CID
provides information that is complimentary to most
other techniques for studying protein gas-phase confor-
mation.
A weakness of the presented CID technique is that it
does not, by any means, provide information on the
overall stability of the peptide ions. For example, it is
unable to distinguish an all-helix peptide from an
all-random coil peptide. However, as shown here, it is
potentially very useful for detecting structural varia-
tions in peptide ions.
In the presented technique, the discrepancies be-
tween the experimental tandem spectrum of a peptide
and its theoretical spectrum predicted from the peptide
fragmentation model are attributed to the secondary/
tertiary structure of the peptide. Apparently, these
discrepancies may also be caused by imperfections in
the fragmentation model. For example, it is potentially
possible that the extremely flexible region detected near
Asp-15 of glucagons 5 (Figure 4) is an artifact caused
by imperfection in the model for highly charged ions.
Ruling out this possibility is difficult due to the lack of
conformational “gold standards” of gaseous peptides.
To serve as a “gold standard” for this technique the
peptide ions must have significant structural variations
inside them and must have detailed structural informa-
tion available for each individual residue. However, the
strong correlations between the gas-phase conforma-
tional stability maps of lower-charged peptides and
their condensed-phase secondary structures demon-
strate that the effect of imperfections in the model is
small, at least for these lower-charged peptide ions.
More work need to be done in understanding the
793J Am Soc Mass Spectrom 2006, 17, 786–794 PEPTIDE GAS-PHASE CONFORMATION BY CIDmechanisms of peptide fragmentation to minimize the
imperfections in the fragmentation model. At this point,
the site-specific information of gaseous peptide/protein
ions will certainly contribute to our understanding of
structure of gaseous peptides/proteins.
Conclusions
Protein CID spectrum, combined with fragmentation
modeling, was used to quantitatively access site-specific
information on conformational stabilities of gaseous
peptide ions. The gas-phase conformational stability
maps of several -helical peptides as determined by this
technique correlate closely with their condensed-phase
secondary structures, suggesting similarities between
the gas-phase and condensed-phase conformations of
these -helical peptides. The strong correlations be-
tween gas-phase and condensed-phase stability maps
also demonstrate that low-energy CID process does not
provide sufficient energy to completely disrupt the
structures of these peptides, as well as the validity of
the presented technique for studying peptide gas-phase
conformations. The site-specific stability map described
here is complementary to the data obtained by more
conventional techniques in that only strong noncova-
lent interactions are monitored. Combining site-specific
stability map with other techniques such as collisional
cross-section measurement, H/D exchange and molec-
ular modeling it is potentially possible to obtain a much
detailed picture of conformation and dynamics of gas-
eous peptides.
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